There are certain clinical situations, where rapid regression of corpus luteum and reduction in sex steroid output and production of vasoactive and angiogenesis promoting factors like VEGF are of paramount importance such as ovarian hyperstimulation syndrome (OHSS). This evidence concerns the gene VEGFA and ovarian hyperstimulation syndrome.